Vabysmo Market Report 2026

Vabysmo Market Overview

• The Vabysmo market growth in the historic period has been driven by improved diagnosis of retinal disorders, expansion of ophthalmology specialty clinics • Market expansion is supported by growing prevalence of diabetic eye diseases, rising demand for durable treatment outcomes • Growth Driver: Rising Incidence Of Ophthalmic Conditions Driving Growth In The Market • Market Trend: Advancement In Vision Care Through Innovative Therapeutics • North America was the largest region in 2025.

What Is Covered Under Vabysmo Market?

Vabysmo is a prescription medication used to treat retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME). It inhibits VEGF and Ang-2, reducing retinal fluid accumulation and preventing vision loss. Vabysmo is administered as an injection into the eye, offering a long-acting treatment option with fewer required injections than traditional therapies. The main indication for vabysmo are wet age-related macular degeneration (wAMD), diabetic macular edema (DME), diabetic retinopathy (DR), uveitis, and retinal vein occlusion. Wet age-related macular degeneration involves the growth of abnormal blood vessels beneath the retina, leading to vision loss in older adults. The various formulations are injectable solutions and pre-filled syringes. These are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, specialty pharmacies, and online pharmacies and are used by various end users such as adults and geriatrics.

What Is The Vabysmo Market Growth Forecast?

The growth in the forecast period can be attributed to growing prevalence of diabetic eye diseases, rising demand for durable treatment outcomes, expansion of personalized ophthalmic care, increased investments in retinal drug development, advancements in biologic drug delivery systems. Major trends in the forecast period include increasing adoption of long-acting retinal therapies, growing demand for reduced injection frequency treatments, expansion of dual-target ophthalmic drugs, rising focus on vision preservation solutions, enhanced use of advanced biologic formulations.

Global Vabysmo Market Segmentation

1) By Indication: Wet Age-Related Macular Degeneration (wAMD), Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), Uveitis, Retinal Vein Occlusion 2) By Formulation: Injectable Solutions, Pre-filled Syringes 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies 4) By End User: Adult, Geriatric

What Are The Drivers Of The Vabysmo Market?

The rising incidence of ophthalmic conditions is expected to propel the growth of the vabysmo market going forward. Ophthalmic conditions are eye-related health issues that can affect vision or eye function, ranging from common problems such as dry eyes to serious diseases such as cataracts, glaucoma, and macular degeneration. The rising incidence of ophthalmic conditions can be attributed to several factors, including an aging population, increased diabetes rates, lifestyle factors, better detection methods, and longer lifespans. Vabysmo helps ophthalmic patients by targeting and inhibiting key proteins responsible for the growth of abnormal blood vessels and fluid leakage in the eye, thereby improving vision and reducing the risk of further damage in conditions such as age-related macular degeneration (AMD) and diabetic macular edema (DME), making it a crucial therapy for preserving sight in affected individuals. For instance, in August 2024, according to the Welsh Government, a UK-based government agency, ophthalmology departments in Wales recorded over 35,000 admissions in 2023-24, marking a 5.8% increase from the previous year. Therefore, the rising incidence of ophthalmic conditions is driving the growth of the vabysmo industry. The growing aging population is expected to propel the growth of the vabysmo market going forward. An aging population is characterized by an increasing proportion of elderly individuals due to longer life expectancy and declining birth rates. The growing aging population is due to several factors, such as longer life expectancy from better healthcare and lower birth rates, resulting in a higher proportion of elderly individuals. Vabysmo benefits the aging population by treating retinal diseases, improving vision, and helping prevent vision loss, which is common in older adults. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. Therefore, the growing aging population is driving the growth of the vabysmo industry.

Key Players In The Global Vabysmo Market

Major companies operating in the vabysmo market are F. Hoffmann-La Roche AG

Global Vabysmo Market Trends and Insights

The key trend in the vabysmo market is focusing on regulatory approvals to expand its reach and gain access to new markets, driving adoption among healthcare providers and ensuring broader patient access to its innovative treatment for retinal diseases. Regulatory approvals are official authorizations granted by government agencies to ensure that a product, such as a drug or medical device, meets safety, efficacy, and quality standards, offering benefits such as market access, consumer trust, and legal compliance. For instance, in December 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, received European Medicines Agency approval for its Vabysmo prefilled syringe for the treatment of three retinal conditions neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema caused by retinal vein occlusion (RVO), which together impact over nine million individuals across Europe. As the first prefilled syringe featuring a bispecific antibody, Vabysmo PFS provides a convenient and ready-to-use option paired with a CE-marked needle designed for intravitreal injections. This is targeting Angiopoietin-2 (Ang-2) and VEGF-A pathways, the treatment stabilizes blood vessels, reduces inflammation, and delivers significant improvements in vision. This innovation streamlines administration for retina specialists and alleviates treatment burdens.

Regional Insights

North America was the largest region in the vabysmo market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vabysmo Market?

The vabysmo market consists of sales of prefilled syringes, preservative-free formulation, vials for reconstitution, and injection. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vabysmo Market Report 2026?

The vabysmo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vabysmo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.